Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Accessed 05 May 2017
Diabetes Mellitus Increases the Risk of Active Tuberculosis: a Systematic Review of 13 Observational Studies
Meanwhile, spatiotemporal mismatches between metabolic modulators and secondary therapies remain a critical barrier for nanotherapeutics
This drug class was originally developed to treat type 2 diabetes
doi: 10.3389/fendo.2020.00365 Received 27 October 2019 Accepted 11 May 2020 Published 09 June 2020 Volume 11 - 2020 Edited by Debbie C
TB-500, a synthetic fragment derived from thymosin beta-4, has been studied for its role in cellular migration, cytoskeletal organization, angiogenesis, and tissue regeneration
US$ 23.26
US$ 25.17
US$ 24.33
